VHL and nonpapillary renal cell carcinoma: However, some studies have reported that targeted therapies for ccRCC could be better treatments; for example, VHL is considered a potential molecular target for ccRCC, and targeting the VHL/VEGFR pathway may play an important role in the treatment of advanced ccRCC [27].